Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
matrix-m1 (1 trial)
mva-np (1 trial)
alpn-101 (1 trial)
ctx-4430 (1 trial)
dabigatran (pradaxa) (1 trial)
mannitol (1 trial)
piperaquinoline (1 trial)
pravastatin (pravachol) (1 trial)
scy-078 (2 trials)
spr206 (1 trial)
Inflammation (Phase 1)
Influenza, Human (Phase 2)
Malaria (Phase 1)
Pneumonia (Phase 1)
Trials (7 total)
Trial APIs (10 total)